WEDNESDAY, Sept. 22, 2021 (HealthDay News) — As many as 18 million Americans can’t afford their prescribed medications, a new nationwide poll finds. That’s 7% of the adult population in the United States. But when it comes to households making less than $24,000 per year, the percentage jumps to 19%,Continue Reading
WEDNESDAY, Sept. 22, 2021 (HealthDay News) — An advisory panel to the U.S. Centers for Disease Control and Prevention will meet on Wednesday to discuss which Americans, if any, should get Pfizer booster shots to rev up their immunity to COVID-19. Their recommendation will follow a decision by a U.S.Continue Reading
WEDNESDAY, Sept. 22, 2021 (HealthDay News) — Antibodies from current COVID-19 vaccines don’t bind well to the new variants of the virus, a study finds. Researchers collected data from previously published papers about the sequence of antibodies produced by the vaccines. They focused on antibodies against the spike protein, aContinue Reading
TUESDAY, Sept. 21, 2021 (HealthDay News) — Older children and kids with chronic diseases are those most likely to wind up in the hospital with COVID-19, researchers have found. Conditions such as obesity, diabetes and neurologic problems, among others, put kids at risk for severe COVID-19, according to a newContinue Reading
TUESDAY, Sept. 21, 2021 (HealthDay News) — As the highly contagious Delta variant has swept across the United States, the country has reached a tragic milestone. COVID-19 has now killed more Americans than the 1918 Spanish flu pandemic did, when roughly 675,000 people died. It didn’t have to be thatContinue Reading
TUESDAY, Sept. 21, 2021 (HealthDay News) — An animal tranquilizer, xylazine, is increasingly linked to drug overdose deaths across the United States, health officials say. According to a new report from the U.S. Centers for Disease Control and Prevention, xylazine has turned up in overdose deaths in 25 of 38Continue Reading
MONDAY, Sept. 20, 2021 (HealthDay News) — New research offers good news for women with an aggressive HER2-positive breast cancer. A targeted therapy, trastuzumab deruxtecan (T-DXd), sold as Enhertu, triples the length of time that the cancer remains in check when compared with the current gold standard, trastuzumab emtansine (T-DM1).Continue Reading
MONDAY, Sept. 20, 2021 (HealthDay News) — Starting in November, the United States plans to lift travel restrictions on people coming from overseas who are fully vaccinated against COVID-19. This move by the Biden administration will open the United States to relatives separated from families as well as business travelers.Continue Reading
MONDAY, Sept. 20, 2021 (HealthDay News) — A smaller dose of Pfizer’s coronavirus vaccine safely triggers a strong immune response in children as young as 5, the company announced Monday morning. “Over the past nine months, hundreds of millions of people ages 12 and older from around the world haveContinue Reading
MONDAY, Sept. 20, 2021 (HealthDay News) — If a person is diagnosed with COVID-19 in the United States right now, it’s almost certainly caused by the Delta variant. The highly transmissible variant, which caused crippling surges in India and Britain this past spring and fueled case spikes in the UnitedContinue Reading